Fighting Fire With Fire?
|
|
- Erik Hill
- 8 years ago
- Views:
Transcription
1 Why Would Anyone Treat Drug Addiction With Drugs? Methadone Maintenance Treatment: Fighting Fire With Fire? Mark Stanford, Ph.D. Sangeetha Raghuraman, M.D. SCVHHS Dept Alcohol & Drug Svcs Addiction Medicine Div. 2008
2 Case Presentation 50 yr old with poorly controlled diabetes. Despite patients best efforts to control his blood sugars, he continues to run high. Patient has voiced concerns to his physician that his dose of insulin is too low
3 Case Presentation (cont.) His physician s response was You re just substituting an addiction to sugar with an addiction to insulin. You just need to make a choice to eat the right foods and exercise more!
4 Case Presentation (cont.) When the patient objected, arguing that he needed his insulin to control his diabetes, the physician relented, but informed the patient that he was only going to prescribe insulin for a few weeks and then he would gradually reduce the dose until it was discontinued.
5 Methadone Maintenance: History 1950 s-1960 s: NYC epidemic heroin use By 1961 death related to heroin injection became #1 cause of death in yr old age group Cost to health care system of 100 billion/yr Treatment options: incarceration, civil commitment, and therapeutic communities Methadone for detox in the 1950 s, but relapse rates >90%
6 Methadone Maintenance: History 1964: Dole and Nyswander (Rockefeller University) pilot study with 6 long term addicts. Morphine failed as a maintenance medication Methadone successfully treated drug craving Eventually all 6 patients stabilized and were able to plan for the future, secure jobs.
7 Methadone Maintenance: patients History 1971: Returning Vietnam veterans with heroin addiction led Nixon to establish Special Office for Drug Abuse Prevention ,000 MM patients nationwide 1995 IOM report estimated 500,000 to 1 million heroin users in U.S. = only 19-36% of heroin users are enrolled in methadone treatment.
8 30 years of independent research shows that.... The success of MMT in reducing crime, death, disease and drug use is well documented. -Death rates among persons on MM 30% less than for those not on treatment Institute of Medicine
9 581 Male Heroin Addicts Followed for 33 Years Hser et al., 2001
10 Methadone Maintenance Since the mid-1960 s, methadone maintenance has been the gold standard for the treatment of opioid dependence. -JAMA (8);961-3
11 DADS Addiction Medicine Division 3 clinics: Central Valley Clinic (on the VMC campus) East Valley Clinic (East San Jose at Alexian) South County Clinic (San Martin) 571 patients: 510 maintenance 50 medically managed withdrawal 7 Suboxone (buprenorphine) patients 4 Perinatal patients
12 Based on the science, how is addiction currently defined? A brain disease expressed as a compulsive behavior The continued abuse of drugs despite negative consequences A chronic, potentially relapsing disorder NIDA. 2004
13 ADDICTION AS A CHRONIC ILLNESS Chronic relapsing condition which untreated may lead to severe complications and death.
14 ADDICTION AS A CHRONIC ILLNESS It is treatable but not curable. Adjustment to diagnosis is part of patient s task. There is a wide spectrum of severity. Retention in treatment is key. Best treatment is integrated.
15 Addiction is a Chronic Illness Because: It has both a genetic and environmental basis influencing its development and manifestation Recovery from it is often a long-term process requiring repeated treatments Relapses can occur during or after successful treatment episodes Participation in self-help support programs during and following treatment can be helpful in sustaining long-term recovery
16 Addiction Diagnosed Any 1 of: DSM-IV Abuse recurrent use causing failure to fulfill major role obligations at work/home/school recurrent use when physically hazardous recurrent substance-related legal problems continued use despite persistent social/interpersonal problems due to substance use DSM-IV Dependence Any 3 of: tolerance withdrawal uses more or longer than intended unable to cut down use consumes a great deal of time important social/work activities given up continued use despite mental or health problems known to be caused by substance
17 Stabilization When a patient is on a stabilized dose of methadone, they no longer meet the DSM IV diagnostic criteria for opioid addiction.
18 Signs of Stabilization abstinence from opioids no switching to other depressants (benzos alcohol, etc) participation in counseling treatment disassociation from drug-using friends and family members involvement with healthy people and activities
19 What is Methadone? a long-acting opiate with a slow onset of action no rush not particularly addicting opiate addicts experience gradual relief from symptoms of withdrawal opiate naïve users experience slow onset of sedation produces/perpetuates physical dependence
20 Why use Methadone? The addicted patient benefits addicts are able to quit using heroin and remain abstinent a therapeutic dose enhances patients ability to pursue education or employment a therapeutic dose enhances patients ability to regain/maintain family relationships
21 Why Use Methadone? (cont) Society benefits decreased transmission of HIV and hepatitis C decreased criminal activity improved pregnancy outcome for opiate addicted patients financial savings
22 Characteristics of a Candidate for Methadone Maintenance moderate to severe addiction demonstrated inability to achieve/maintain abstinence with other treatment modalities physiological dependence on opiates for longer than one year OR any pregnant woman with evidence of physical dependence on opiates
23 Methadone maintenance: an evidence-based medical treatment Stigmatized in spite of saving many lives and lots of money Urban legends persist, including it s just another drug.
24 Four questions patients ask: Is methadone better than heroin? What is the right dose of methadone? How long should patients stay on methadone? What are the side effects of methadone?
25 First question: Is methadone better than heroin? Legal Avoids needles Known amount ingested (this is what patients already know, but there is more to it )
26 Methadone Simulated 24 Hr. Dose/Response At steady-state in tolerant patient Dose Response Loaded High Normal Range Comfort Zone Subjective w/d Sick Objective w/d 0 hrs. Time 24 hrs. Opioid Agonist Treatment of Addiction - Payte
27 Is methadone better than heroin? Legal Avoids needles Known amount ingested Slow onset: no rush Long acting: can maintain comfort or normal brain function Stabilized physiology, hormones, tolerance
28 Four questions patients ask: second question Is methadone better than heroin? What is the right dose of methadone? How long should patients stay on methadone? What are the side effects of methadone?
29 How Much???? Enough!!! Tom Payte, MD
30 What is the right dose? Eliminate physical withdrawal Eliminate craving Comfort/function: usually trough is ng/ml, peak no more than twice the trough. (see stars on the next graph) Not over-sedated Blocking dose
31 Methadone Simulated 24 Hr. Dose/Response At steady-state in tolerant patient Dose Response Loaded High Normal Range Comfort Zone Subjective w/d Abnormal Normality trough Sick Objective w/d 0 hrs. Time 24 hrs. Opioid Agonist Treatment of Addiction - Payte
32 A Non-therapeutic Dose Jeopardizes the success of treatment. Sub-therapeutic dosing (under-dosing) results in physical discomfort and ongoing use. Over-dosing causes physical discomfort and over-sedation.
33 Effectiveness of Methadone Treatment: Dose Adequacy Past month heroin use (%) Daily Methadone Dose (in mgs.) Adapted from V. Dole (1989) JAMA, 282, p. 1881
34 Methadone Is NOT A Heroin Substitute
35 Methadone Pharmacology compared to heroin, the patient is stabilized high Day 1 Day 2 Day 3 Day 1 Day 2 Day 3 normal sick Heroin Methadone
36 Stabilization means patient experiences no withdrawal between doses cravings are minimized no drowsiness or sedation no euphoria if other opioids are used because the opioid receptors are blocked no medically significant or subjectively intolerable side effects no longer meets DSM IV diagnosis for opioid dependency
37 Four questions patients ask: third question Is methadone better than heroin? What is the right dose of methadone? How long should patients stay on methadone? What are the side effects of methadone?
38 How Long??? Long Enough!! Tom Payte, MD
39 Relapse to heroin use after MMT- 105 patients who left treatment 90% % 80% I V 70% 60% 50% 57.6% 72.7% 82.1% U S E R S 40% 45.5% 30% 20% 28.9% 10% 0% In Tx. 1 to 3 4 to 6 7 to 9 10 to 12 Months Since Stopping Treatment Adapted from: Ball & Ross, 1991.
40 How Long For Methadone Treatment? 120 P e r c e n t % 67% 23% 8% 0 Pretreatment Admission: < 6 months stay Average Stay: 6 to 54 months Long-term: > 54 months Adapted from: Ball & Ross, 1991.
41 Four questions patients ask: fourth question Is methadone better than heroin? What is the right dose of methadone? How long should patients stay on methadone? What are the side effects of methadone?
42 Opiate effects - physical Predictable physical effects of administering opiates: Tolerance: the body becomes efficient in processing the drug and requires ever higher doses to produce the desired effect. Dependence: when the drug is discontinued there are typical withdrawal signs and symptoms.
43 Side effects of methadone: General opiate effects: Sedation/stimulation Maintained phys. dependence (stable) Hypogonadism (not as severe as with heroin, may be dose dependent) Constipation Slight QTc prolongation on ECG (Martell etal) Sweating Methadone treatment tied to regulated clinic
44 What is the QT and Why Does It Matter? When the heart contracts it emits an electrical signal, which can be recorded on an electrocardiogram (ECG). On a paper readout strip, the ECG produces a characteristic waveform with the different parts designated by letters - such as Q, R, S, and T The QT interval represents the time for electrical activation and relaxation of the ventricles, which is measured in fractions of a second, or milliseconds (msec). It is an indicator of either healthy or abnormal heart rhythm.
45 What is the QT and Why Does It Matter? When the QTc becomes significantly prolonged, the person may be at risk of developing a particularly rapid, abnormal heart rhythm, called torsade de pointes, or TdP. This literally means 'twisting of the points' and is represented on the ECG by undulating peaks twisting about a central axis. This may signal convulsive twitching of heart muscle, or ventricular fibrillation, which can cause death if emergency care is not provided [Leavitt and Krantz 2003].
46 Case Reports Are Inadequate There have been various case reports of QTc interval prolongation and serious arrhythmia, TdP, in patients prescribed methadone. These cases often, but not always, appear to be more commonly associated with higher-dose treatment (> 200 mg/day) [Pearson and Woosley 2005]. In the majority of those involving typical MMT doses, additional medications, illicit drug use, and/or clinical conditions such as low potassium levels were noted as contributing factors.
47 Case Reports Are Inadequate An examination of all methadone adverse-event cases reported to the FDA spanning more than 3 decades found only a 0.29% incidence of QT prolongation and 0.79% incidence of TdP. [Pearson and Woosley 2005]. They conceded that it was impossible to be "absolutely certain if methadone caused or contributed to the prolonged QT and TdP." Therefore, while case reports can be of use in signaling a possible problem, in themselves they are weak evidence of methadone being a primary or even significant contributor to cardiac disturbances.
48 Treatment Outcome Data Treatment Outcome Data 4-5 fold reduction in death rate reduction of drug use reduction of criminal activity engagement in socially productive roles reduced spread of HIV excellent retention Joseph et al, 2000, Mt. Sinai J.Med., vol67, # 5, 6
49 Outcomes Methadone Reduces: overall and overdose deaths Illicit drug use criminal behavior spread of infectious diseases (HIV, HCV and TB) Is not a cure
50 HIV CONVERSION IN TREATMENT 25% 20% 15% 10% Tx Status 5% 0% In Tx (N=95) Partial Tx (N=45) No Tx (N=55) Source: Metzger, D. et. al 18 month HIV conversion by treatment retention. J of AIDS 6:1993. p.1053
51 Methadone Treatment Reduces Criminal Behavior Drug offense arrests decline because MMT patients reduce or stop buying and using illegal drugs. Arrests for predatory crimes decline because MMT patients no longer need to finance a costly heroin addiction, and because treatment allows many patients to stabilize their lives and return to legitimate employment. Hubbard, R.J. Treatment Outcomes Prospective Study, op. cit; J.C. Ball. The Criminal Justice System and Opiate Addiction. NUIDA Research Monograph 86.
52 Crime among 491 patients before and during MMT at 6 programs 300 Crime Days Per Year Before TX During TX 0 A B C D E F Adapted from Ball & Ross - The Effectiveness of Methadone Maintenance Treatment, 1991
53 Pregnancy MMT treatment of choice for pregnant, opioid-abusing women. Efforts to avoid intra-uterine fetal withdrawal, including split dose. Neonatal withdrawal occurs within 72 hours, at least 45% need treatment. Breastfeeding recommended if not HIV positive.
54 Pain in patients on MMT Methadone is prescribed for pain treatment in twice or three times daily doses. Up to 60% of MMT patients have chronic pain (Jamison 2000, Rosenblum 2003) Split doses may be indicated.
55 Methadone Treatment Is More Effective With... counseling (individual/group) urine testing involvement in community recovery groups lifestyle changes to support recovery mental health evaluation/treatment medical assessment/referral
56 Evidence for Counseling In Methadone Maintenance The dose of these services can determine treatment outcomes McLellan et al., 1993: 6-month randomized clinical trial three levels of psychological services methadone alone methadone plus standard counseling services methadone plus enhanced services (counseling, medical/psychiatric, employment, and family therapy)
57 Evidence for Counseling Services in Methadone Maintenance Outcome Methadone Methadone + Std. Counseling Methadone + Enhanced Counseling Retention 31% 59% 81% >16 consecutive weeks of (-) urines 0% 28% 55%
58 A FEW WORDS ABOUT BUPRENORPHINE Ceiling effect and safety Displaced other opiates: withdrawal on induction Sublingual tablet Schedule 3(methadone is 2) One form combined with naloxone Office based use available
59 Slide: courtesy Reckitt Benkiser
60
61 Buprenorphine is a Partial Agonist Full Agonist (e.g. methadone) % Mu Receptor Intrinsic Activity Partial Agonist (e.g. buprenorphine) 10 0 no drug low dose Antagonist (e.g. naloxone) high dose DRUG DOSE
62 Differences in Precipitated Syndromes Buprenorphine will precipitate withdrawal only when it displaces a full agonist off the mu receptors % Mu Receptor Intrinsic Activity Full agonist (e.g. heroin) A Net Decrease in Receptor Activity if a Partial Agonist displaces the Full Agonist Partial agonist (e.g. buprenorphine) 0 no drug low dose high dose DRUG DOSE
63 Receptor Affinity Affinity is the strength with which a drug physically binds to a receptor Buprenorphine affinity is very strong and it will displace full agonists like heroin and methadone Note receptor binding strength (strong or weak) is NOT the same as receptor activation (agonist or antagonist) Mu Receptor Bup affinity is higher Bound to receptor Therefore, Full Agonist is displaced Judith Martin, MD. COMP 2004
64 Receptor Dissociation Dissociation is the speed (slow or fast) of disengagement or uncoupling of a drug from the receptor Buprenorphine s dissociation is slow Therefore Buprenorphine stays on the receptor a long time and blocks heroin or methadone from binding Mu Receptor Bup dissociation is slow Therefore, Full Agonists can t bind Judith Martin, MD. COMP 2004
65 100 Buprenorphine, Methadone, LAAM: Treatment Retention Percent Retained % Hi Meth 58% Bup 53% LAAM 20% Lo Meth Study Week Johnson et al, 2000
66 Methadone Maintenance Treatment Fighting Fire With Fire? Yes! In some cases, it s the best way to stop an otherwise out of control and devastating situation!
67 Websites for more info on Medication-Assisted Treatment
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate
More informationMedication-Assisted Addiction Treatment
Medication-Assisted Addiction Treatment Molly Carney, Ph.D., M.B.A. Executive Director Evergreen Treatment Services Seattle, WA What is MAT? MAT is the use of medications, in combination with counseling
More informationConsiderations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT
Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA
More informationUpdate on Buprenorphine: Induction and Ongoing Care
Update on Buprenorphine: Induction and Ongoing Care Elizabeth F. Howell, M.D., DFAPA, FASAM Department of Psychiatry, University of Utah School of Medicine North Carolina Addiction Medicine Conference
More informationSubstitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015
Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid
More informationMethadone Maintenance. Judith Martin, MD Medical Director BAART Turk Street Clinic San Francisco, CA
Methadone Maintenance Judith Martin, MD Medical Director BAART Turk Street Clinic San Francisco, CA Dr. Martin, Disclosures No conflict of interest to disclose. No discussion of off-label use. Special
More informationHow To Treat Anorexic Addiction With Medication Assisted Treatment
Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious
More informationNeurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011
Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids
More informationOpioid/Opiate Dependent Pregnant Women
Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than
More informationIntegrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings
Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings All-Ohio Conference 3/27/2015 Christina M. Delos Reyes, MD Medical Consultant,
More informationUsing Drugs to Treat Drug Addiction How it works and why it makes sense
Using Drugs to Treat Drug Addiction How it works and why it makes sense Jeff Baxter, MD University of Massachusetts Medical School May 17, 2011 Objectives Biological basis of addiction Is addiction a chronic
More informationMedication treatments for opioid use disorders
Medication treatments for opioid use disorders Summary for counties JUDITH MARTIN, Medical Director of Substance Use Services, San Francisco Department of Public Health Brief history of Methadone and Buprenorphine
More informationCare Management Council submission date: August 2013. Contact Information
Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing
More informationTreatment of opioid use disorders
Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call
More informationLike cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.
Heroin Introduction Heroin is a powerful drug that affects the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants to.
More informationOne example: Chapman and Huygens, 1988, British Journal of Addiction
This is a fact in the treatment of alcohol and drug abuse: Patients who do well in treatment do well in any treatment and patients who do badly in treatment do badly in any treatment. One example: Chapman
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)
More informationMEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and
More informationBuprenorphine/Naloxone Maintenance Treatment for Opioid Dependence
Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Information for Family Members Family members of patients who have been prescribed buprenorphine/naloxone for treatment of opioid addiction
More informationFrequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction
Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction March 3, 2008 By: David Rinaldo, Ph.D., Managing Partner, The Avisa Group In this FAQ What medications are currently
More informationSection Editor Andrew J Saxon, MD
Official reprint from UpToDate www.uptodate.com 2015 UpToDate Pharmacotherapy for opioid use disorder Author Eric Strain, MD Section Editor Andrew J Saxon, MD Deputy Editor Richard Hermann, MD All topics
More informationUse of Buprenorphine in the Treatment of Opioid Addiction
Use of Buprenorphine in the Treatment of Opioid Addiction Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Executive Summary Which of the following is an
More informationDrugFacts: Treatment Approaches for Drug Addiction
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please
More informationDependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania
Dependence and Addiction Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania Overview Heroin and other opiates The disease of heroin addiction or dependence Effective
More informationDeath in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by
More informationHeroin Overdose Trends and Treatment Options. Neil A. Capretto, D.O., F.A.S.A.M. Medical Director
Heroin Overdose Trends and Treatment Options Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Type date here www.gatewayrehab.org Drug Overdose Deaths Increasing in Allegheny County Roberta Lojak holds
More informationMedication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment
Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment Introduction March 3, 2008 By: Suzanne Gelber, MSW, Ph.D., Managing Partner, The Avisa Group Defining Characteristics
More informationEver wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier?
Ever wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier? Good News: Medical treatments called opioid (oh-pee-oyd) maintenance can help you! Injecting heroin puts you
More informationMedication Assisted Treatment
Medication Assisted Treatment Tanya Hiser, MS, LPC State Opioid Treatment Authority Bureau Of Prevention, Treatment, & Recovery State of Wisconsin Elizabeth Collier, MSW, CSAC, ICS, LCSW TANF Best Practice
More informationHeroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
More informationOpioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist
Opioid Addiction and Methadone: Myths and Misconceptions Nicole Nakatsu WRHA Practice Development Pharmacist Learning Objectives By the end of this presentation you should be able to: Understand how opioids
More informationJoel Millard, DSW, LCSW Dave Felt, LCSW
Joel Millard, DSW, LCSW Dave Felt, LCSW 1. Provide an overview of the effectiveness of medication assisted treatment, to include a discussion of the different types of medications and how they are used
More informationUsing Buprenorphine in an Opioid Treatment Program
Using Buprenorphine in an Opioid Treatment Program Thomas E. Freese, PhD Director of Training, UCLA Integrated Substance Abuse Programs Director, Pacific Southwest Addiction Technology Transfer Center
More informationTreatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism
Treatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School of Medicine University
More informationHeroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
More informationTENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION
TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION The Tennessee Board of Medical Examiners has reviewed the Model Policy Guidelines for Opioid Addiction Treatment
More informationOVERVIEW OF MEDICATION ASSISTED TREATMENT
Sarah Akerman MD Assistant Professor of Psychiatry Director of Addiction Services Geisel School of Medicine/Dartmouth-Hitchcock Medical Center OVERVIEW OF MEDICATION ASSISTED TREATMENT Conflicts of Interest
More informationThe ABCs of Medication Assisted Treatment
The ABCs of Medication Assisted Treatment J E F F R E Y Q U A M M E, E X E C U T I V E D I R E C T O R C O N N E C T I C U T C E R T I F I C A T I O N B O A R D The ABCs of Medication Assisted Treatment
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call the
More informationTreatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective
Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective Dale K. Adair, MD Medical Director/Chief Psychiatric Officer OMHSAS 1 Treatment and Interventions for
More informationHeroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain?
Heroin Heroin is a synthetic opiate drug that is highly addictive. It is made from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears
More informationBuprenorphine: what is it & why use it?
Buprenorphine: what is it & why use it? Dr Nicholas Lintzeris, MBBS, PhD, FAChAM Locum Consultant, Oaks Resource Centre, SLAM National Addiction Centre, Institute of Psychiatry Overview of presentation
More informationMinimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:
Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society
More informationThe Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office
The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office Adopted April 2013 for Consideration by State Medical Boards 2002 FSMB Model Guidelines
More informationMedications for Alcohol and Drug Dependence Treatment
Medications for Alcohol and Drug Dependence Treatment Robert P. Schwartz, M.D. Medical Director Rschwartz@friendsresearch.org Friends Research Institute Medications for Alcohol Dependence Treatment Disulfiram
More informationHulpverleningsmodellen bij opiaatverslaving. Frieda Matthys 6 juni 2013
Hulpverleningsmodellen bij opiaatverslaving Frieda Matthys 6 juni 2013 Prevalence The average prevalence of problem opioid use among adults (15 64) is estimated at 0.41%, the equivalent of 1.4 million
More informationPutting Addiction Treatment Medications to Use: Lessons Learned
Putting Addiction Treatment Medications to Use: Lessons Learned George E. Woody, M.D. Laura McNicholas, M.D., Ph.D. Department of Psychiatry, University of Pennsylvania School of Medicine and Philadelphia
More informationThe Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction
The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction James H. Barger, MD SAPC Medical Director and Science Officer Desiree A. Crevecoeur-MacPhail, Ph.D.
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: PDP IBT Inj - Vivitrol Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Opiate Antagonist Client: 2007 PDP IBT Inj Approval Date: 2/20/2007
More informationIN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act
IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This
More informationOpioid Treatment Services, Office-Based Opioid Treatment
Optum 1 By United Behavioral Health U.S. Behavioral Health Plan, California Doing Business as OptumHealth Behavioral Solutions of California ( OHBS-CA ) 2015 Level of Care Guidelines Opioid Treatment Services,
More informationFrequently asked questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently asked questions What is Naltrexone? Naltrexone is a prescription drug that completely blocks the effects of all opioid drugs
More informationMedication-Assisted Treatment for Opioid Addiction
Medication-Assisted Treatment for Opioid Addiction This document contains a general discussion of medications approved by the U.S. Food and Drug Administration (FDA) for use in the treatment of opioid
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2011 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationUnderstanding Addiction: The Intersection of Biology and Psychology
Understanding Addiction: The Intersection of Biology and Psychology Robert Heimer, Ph.D. Yale University School of Public Health Center for Interdisciplinary Research on AIDS New Haven, CT, USA November
More informationEPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.
Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF
More informationEPIDEMIOLOGY OF OPIATE USE
Opiate Dependence EPIDEMIOLOGY OF OPIATE USE Difficult to estimate true extent of opiate dependence Based on National Survey of Health and Mental Well Being: 1.2% sample used opiates in last 12 months
More informationMAT Counselor Education Course Exam Questions Packet Part 1
MAT Counselor Education Course Exam Questions Packet Part 1 Course No: Course Title: Course Objective: MA-1901P1 Medication-Assisted Treatment (MAT) Counselor Education Course Part 1 Includes primer on
More informationNarcotic Replacement Therapy Policy San Mateo County Alcohol and Other Drug Services. Lea Goldstein, Ph.D. Brian Greenberg, Ph.D.
Narcotic Replacement Therapy Policy San Mateo County Alcohol and Other Drug Services Lea Goldstein, Ph.D. Brian Greenberg, Ph.D. The Narcotic Replacement Therapy (NRT) Policy Narcotic replacement programs
More informationMEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Sidarth Wakhlu,M.D. Addiction Team Leader North Texas VA Health Care System Addiction Psychiatry Fellowship Director Associate Professor Of Psychiatry
More informationBuprenorphine Therapy in Addiction Treatment
Buprenorphine Therapy in Addiction Treatment Ken Roy, MD, FASAM Addiction Recovery Resources, Inc. River Oaks Hospital Tulane Department of Psychiatry www.arrno.org Like Minded Doc What is MAT? Definition
More informationNaltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,
More informationOpiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,
More informationOpioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
More informationOpioid Addiction & Corrections
Opioid Addiction & Corrections Medication Assisted Treatment in the Connecticut Department of Correction April 30, 2015--CJPAC Kathleen F. Maurer, MD, MPH, MBA Medical Director and Director of Health and
More informationMEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT. An Outpatient Model
MEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT An Outpatient Model OBJECTIVE TO PRESENT A PROTOCOL FOR THE EVALUATION AND TREATMENT OF PATIENTS WHO ARE CHEMICALLY DEPENDENT ON OR SEVERLY
More informationTreatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy
Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,
More informationEstablished in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay.
Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay. Patients are not denied treatment if they do not have the ability to pay for services Schedule
More informationBeyond SBIRT: Integrating Addiction Medicine into Primary Care
Beyond SBIRT: Integrating Addiction Medicine into Primary Care Community Clinic Association of Los Angeles County 14 th Annual Health Care Symposium March 6, 2015 Keith Heinzerling MD, Karen Lamp MD; Allison
More informationJohn R. Kasich, Governor Orman Hall, Director
John R. Kasich, Governor Orman Hall, Director 2 3 Epidemics of unintentional drug overdoses in Ohio, 1979-2011 1,2,3 1800 1600 1400 1200 1000 800 Prescription drugs are causing a larger overdose epidemic
More informationOpiate Abuse and Mental Illness
visited on Page 1 of 5 LEARN MORE (HTTP://WWW.NAMI.ORG/LEARN-MORE) FIND SUPPORT (HTTP://WWW.NAMI.ORG/FIND-SUPPORT) GET INVOLVED (HTTP://WWW.NAMI.ORG/GET-INVOLVED) DONATE (HTTPS://NAMI360.NAMI.ORG/EWEB/DYNAMICPAGE.ASPX?
More informationAllyse Adams PC, LICDC Oriana House, Inc.
Allyse Adams PC, LICDC Oriana House, Inc. 98 Heroin Overdose Deaths from 1/1/2015-7/26/2015 Last year enough narcotic pain medicines were prescribed to supply 67 pills to every man, woman and child In
More informationARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E
BULLETIN INTELLIGENCE Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E NDIC Within the past 2 years buprenorphine a Schedule III drug has been made available for use
More informationMethadone treatment Information for service users Page
South London and Maudsley NHS Foundation Trust Methadone treatment Information for service users Page What can happen if I stop using heroin? If you are addicted to or dependent on heroin, you develop
More informationWhat is Addiction? DSM-IV-TR Substance Abuse Criteria
Module 2: Understanding Addiction, Recovery, and Recovery Oriented Systems of Care This module reviews the processes involved in addiction and what is involved in recovering an addiction free lifestyle.
More informationDrug Addiction Is a Disease So What Do We Do about It?
Drug Addiction Is a Disease So What Do We Do about It? L E S S O N 5 Elaborate/Evaluate Photo courtesy of Gray Wolf Ranch Wilderness Recovery Lodge. Overview Students make predictions about the success
More informationST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;/13;06/14;07/15 WRITTEN BY Jim Johnson Page 1 REVISED BY AUTHORIZED BY Jessica Moeller Debra Johnson I. APPLICATION: THUMB
More informationA G U I D E F O R U S E R S N a l t r e x o n e U
A GUIDE FOR USERS UNaltrexone abstinence not using a particular drug; being drug-free. opioid antagonist a drug which blocks the effects of opioid drugs. dependence the drug has become central to a person
More informationReintegration. Recovery. Medication-Assisted Treatment for Alcohol Dependence. Reintegration. Resilience
Reintegration Recovery Medication-Assisted Treatment for Alcohol Dependence Reintegration Resilience 02 How do you free yourself from the stress and risks of alcohol dependence? Most people cannot do it
More informationJoanna L. Starrels. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume VIII, 2003-2004. A. Study Purpose and Rationale
Outpatient Treatment of Opiate Dependence with Sublingual Buprenorphine/Naloxone versus Methadone Maintenance: a Randomized Trial of Alternative Treatments in Real Life Settings Joanna L. Starrels A. Study
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San
More informationSubstance Abuse lifestyle Concern for mother - fetus - and - neonate
OBJECTIVES Learn about types of opioids and associated withdrawal symptoms Learn what medications are available to treat opioid addiction Understand the pros and cons associated with each medication Understand
More informationUse of Vivitrol for Alcohol and Opioid Addiction
Use of Vivitrol for Alcohol and Opioid Addiction Ken Bachrach, Ph.D. Clinical Director, Tarzana Treatment Centers, Inc. kbachrach@tarzanatc.org What is Vivitrol? An injectable from of naltrexone, which
More informationQuick Guide. For Physicians. Based on TIP 40 Clinical Guidelines for the Use of Buprenorphine in the Treatment. of Opioid Addiction TIP
Buprenorphine Clinical Guide Quick Guide For Physicians Based on TIP 40 Clinical Guidelines for the Use of Buprenorphine in the Treatment Clinical Guidelines for the Use of Buprenorphine in the Treatment
More informationProgram Assistance Letter
Program Assistance Letter DOCUMENT NUMBER: 2004-01 DATE: December 5, 2003 DOCUMENT TITLE: Use of Buprenorphine in Health Center Substance Abuse Treatment Programs TO: All Bureau of Primary Health Care
More informationFrom the street to the NICU. Richard Christensen, PA, CAS
From the street to the NICU Richard Christensen, PA, CAS Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a stand-alone
More informationJennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry
Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START) Jennifer
More informationKAP Keys. For Physicians. Based on TIP 40 Clinical Guidelines for the Use of Buprenorphine in the Treatment. of Opioid Addiction
Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction Knowledge Application Program KAP Keys For Physicians Based on TIP 40 Clinical Guidelines for the Use of Buprenorphine
More informationOpioids and Medications to Treat Opioid Dependence
Opioids and Medications to Treat Opioid Dependence Colleen T. LaBelle BSN, RN-BC, CARN Program Director STATE OBOT B Boston University School of Medicine Boston Medical Center Colleen T LaBelle, RN, CARN
More informationMEDICATION-ASSISTED DRUG TREATMENT AND CHILD WELL-BEING
MEDICATION-ASSISTED DRUG TREATMENT AND CHILD WELL-BEING Lena Lundgren, Ph.D.¹ Nancy K. Young, P.h.D.² Therese Fitzgerald, M.S.W.¹ Cat Oettinger, B.A. ¹ ¹ Center on Work and Family, Boston University ²
More informationOffice-based Treatment of Opioid Dependence with Buprenorphine
Office-based Treatment of Opioid Dependence with Buprenorphine David A. Fiellin, M.D Professor of Medicine, Investigative Medicine and Public Health Yale University School of Medicine Dr. Fiellin s Disclosures
More informationSuboxone Programs: Treating Opioid Dependence in CHCs Andrew Putney, MD Medical Director SSTAR ATS and CHC, Fall River, Massachusetts
Suboxone Programs: Treating Opioid Dependence in CHCs Andrew Putney, MD Medical Director SSTAR ATS and CHC, Fall River, Massachusetts Educational Objectives: Review epidemiology of opioid addiction in
More informationFederal Response to Opioid Abuse Epidemic
Healthcare Committee Federal Response to Opioid Abuse Epidemic On May 1, 20215 the Energy and Commerce Subcommittee on Oversight and Investigations held a hearing entitled What is the Federal Government
More informationApplicant Webinar for BJA s Drug Court Discretionary Grant Solicitation
Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation Cynthia Caporizzo, Senior Criminal Justice Advisor, Office of National Drug Control Policy (ONDCP) - Review of the administration
More information5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279. Welcome
5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279 Welcome Welcome to Starlight Behavioral Health Opiate Dependence program. At Starlight, we believe that addiction is
More informationBUPRENORPHINE. the facts about. for Treatment of Opioid Addiction
the facts about BUPRENORPHINE for Treatment of Opioid Addiction U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment
More informationBUPRENORPHINE TREATMENT
BUPRENORPHINE TREATMENT Curriculum Infusion Package (CIP) Based on the Work of Dr. Thomas Freese of the Pacific Southwest ATTC Drug Addiction Treatment Act of 2000 (DATA 2000) Developed by Mountain West
More informationIdentifying and Managing Substance Use During Pregnancy
Identifying and Managing Substance Use During Pregnancy Joseph B. Landwehr, Jr., MD Director, Perinatal Center IU Health Ball Memorial Hospital OBJECTIVES Overview of illicit drug use in pregnant women
More informationGuidance for Disease Management in Correctional Settings OPIOID DETOXIFICATION
1145 W. Diversey Pkwy. 773-880-1460 Chicago, Illinois 60614 www.ncchc.org Guidance for Disease Management in Correctional Settings OPIOID DETOXIFICATION NCCHC issues guidance to assist correctional health
More information